Navigation Links
Conference on cell therapy includes new session on stem cells for non-cardiac organ injury
Date:1/5/2009

WHAT:

The Fifth International Conference on Cell Therapy for Cardiovascular Disease (IC3D) will include a new session on stem cells for non-cardiac organ injury. The session will include new data on stem cells for islet disease and diabetes, bone marrow cells for stroke patients, and treating Parkinson's disease with bone marrow cells.

Highlights from other sessions include the first human data using special bone marrow and adipose cells for heart attack patients and a discussion of the rapid advances in tissue engineering and how surgeons should prepare for this next stage of stem cell therapy.

WHY:

IC3D, one of the largest conferences of its kind with more than 60 internationally recognized faculty members, is a three-day comprehensive program dedicated to the evolving field of cell-based therapies for cardiac repair and regeneration. The theme of this year's meeting is "Cellular and Molecular Building Blocks: Strategies for Cardiovascular Reconstruction in 2009."

The conference encompasses all aspects of cell-based therapeutic approaches to cardiovascular diseases. Research presented at IC3D will touch upon clinical studies of stem cell repair of the heart, brain and peripheral arteries, new sources of adult stem cells and the status of embryonic stem cell research. Each day of the conference will focus on the following diseases and the future role of cell-based therapies.

PROGRAM SPECIFICS:

New sessions for 2009 will include:

  • Major advances in treating peripheral vascular disease
  • Combined cell and tissue regenerative methods
  • Changing the potential of stem cells: Why should we try? How do we do it?
  • New paradigms for the surgeon? How soon will engineered tissue be in the clinic?
  • Discoveries beyond the heart, including the brain and other organs
  • Expanded sessions on Industry Innovations in 2009

The full agenda can be found at:
'/>"/>

Contact: Judy Romero
jromero@crf.org
212-851-9311
Cardiovascular Research Foundation
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Labopharm to host conference call to discuss FDA approval of once-daily RYZOLT(TM) on Tuesday, January 6, 2009 at 8:30 a.m. (ET)
2. Alexion to Present at the 27th Annual JP Morgan Healthcare Conference
3. ViroPharma to Present at the 27th Annual J.P. Morgan Healthcare Conference
4. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 13, 2009
5. WellPoint to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 28, 2009
6. 40 Days for Life Leader to Speak at Personhood Conference
7. Delcath Systems to Host Quarterly Update Conference Call
8. Medco CEO to Present at the 2009 Goldman Sachs Healthcare CEOs Unscripted: A View from the Top Conference
9. Spending Too Much on Healthcare? This Employer-Designed Conference Will Inspire!
10. Hospira to Present at J.P. Morgans 27th Annual Healthcare Conference January 14
11. Abaxis, Inc. to Present at Needham & Companys Eleventh Annual Growth Stock Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/10/2009)...zerland, Nov. 10 ,, ... Q4 2009 Q4 2008 % Change FY 2...-- ------- -------- ------- ------- --------, ...$17,237 $20,199 (15)%, Income (Loss) from,... $264 (22)% ($1,833) $1,095 -, Di...
(Date:11/10/2009)... At a time when health is a major concern for man...uncertain, Easy Pha-max, an internationally recogn...tates. Consumers now have more options to consider...t better time to have options than now. Easy Pha-m...al products that can address many health concerns ...
(Date:11/10/2009)... It is now possible to achieve exceptionally smoo... of hard materials such as ceramics, carbide and h...he new Diamond Flex-Hone® honing tool from B... Los Angeles (PRWEB) November 10, 2009 -- Using ...ed to the ends of flexible filaments, the Diamond ...
(Date:11/9/2009)... Businesses of all sizes looking to fast-track pr...mic have a new resource at their disposal. , ...9, 2009 -- Human resource (HR) professionals looki... for the H1N1 pandemic have a new resource at thei...nter for Infectious Disease Research and Policy (C...
(Date:11/9/2009)...a, Nov. 9 /PRNewswire-Asia-FirstCall/ -- Mindray M...ng developer, manufacturer and,marketer of medical...naudited,financial results for the third quarter a...ighlights for Operations as of September 30, 2009,... million, an increase of, 3.1% over the thir...
Breaking Medicine News(10 mins):Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 2Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 3Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 4Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 5Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 6Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 7Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 8Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 9Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 10Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 11Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 12Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 13Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 14Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 15Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 16Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 17Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 18Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 19Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 20Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 21Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 22Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 23Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 24Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 25Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 26Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 27Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 28Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 29Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 30Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 31Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 32Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 33Health News:Major Biotechnology Franchise Company Expands Rapidly Throughout the USA Amidst Mounting Health Concerns 2Health News:Diamond Honing Tool Technology: The New Standard in Surface Finishing of Hard Materials 2Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 2
...stitute (NHLBI) of the National Institutes of Heal...ng North American clinical trial of diabetes and c...y concerns after review of available data, althoug... to intensively lower blood glucose (sugar) below ...
... mark,its 10th anniversary of delivering identity ...industry, Sentillion, the company that created hea...r-end results. In Q4, Sentillion,added 10 new cust...ity and access management products for single,sign...
...t Increase in Sales from Same ... Greenway Medical Technologies,Inc., a leading pr...R),practice management and interoperability functi...me period in fiscal 2007,and 83 percent from the s...
...out suspected cancer-causing agents, such as deodo...sessment tool has been developed through the Cance...rra Health (SESIH) by a University of New South Wa...y such as using deodorants, artificial sweeteners ...
...es, constructed with soft lithography, should boos...re brain-behavior connections and to screen new ph... infections in humans, report 10 scientists at thr...iled in a paper appearing online ahead of regular ...
...Inc., a global,supplier of infant formulas and nut...anies to accommodate its growing number of interna... into Asia, where it formed PBM,(Guangzhou) Nutrit...007,the magazine,s annual ranking of America,s fas...
Other Medicine News:Health News:Intensive blood sugar treatment in trial of diabetes and cardiovascular disease changed 2Health News:Intensive blood sugar treatment in trial of diabetes and cardiovascular disease changed 3Health News:Intensive blood sugar treatment in trial of diabetes and cardiovascular disease changed 4Health News:Intensive blood sugar treatment in trial of diabetes and cardiovascular disease changed 5Health News:Sentillion Announces Strong Q4 Performance; Signs 10 New Customers; Sells 95,800 Licenses 2Health News:Sentillion Announces Strong Q4 Performance; Signs 10 New Customers; Sells 95,800 Licenses 3Health News:Greenway Medical Technologies Continues Record Setting Growth 2Health News:Greenway Medical Technologies Continues Record Setting Growth 3Health News:Greenway Medical Technologies Continues Record Setting Growth 4Health News:Reducing cancer panic 2Health News:New devices to boost nematode research on neurons and drugs 2Health News:New devices to boost nematode research on neurons and drugs 3
(Date:11/9/2009)...stCall/ -- Volcano Corporation (Nasdaq: VOLC ), a...of products for the diagnosis and treatment of cor...at it will be participating in the Third Annual Ca...mber 10. ,, The presentation by Scott Huenneken...in at 1 p.m., Pacific Standard Time (4 p.m., Easte...
(Date:11/9/2009)...a., Nov. 9 Hill-Rom (N...e formation of a joint venture that will focus on ... of surface replacement systems that are intended ...ements for surfaces that are technologically obsol... a global leader in patient support systems and re...
(Date:11/9/2009)...Asia-FirstCall/ -- American Oriental,Bioengineerin...a pharmaceutical,company dedicated to improving he...ercialization of a broad range of prescription and...d that it plans to release third quarter 2009,fina...the market closes. , The Company will hol...
Breaking Medicine Technology:Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast 2Hill-Rom and Encompass Group Form Joint Venture 2Hill-Rom and Encompass Group Form Joint Venture 3Hill-Rom and Encompass Group Form Joint Venture 4Hill-Rom and Encompass Group Form Joint Venture 5New Drug Could Work Against Leukemia 50663 1Sexist jokes favor the mental mechanisms that justify violence against women 50661 1Sexist jokes favor the mental mechanisms that justify violence against women 50661 2Center receives grant renewal for hypertension and vascular disease studies 50659 1Center receives grant renewal for hypertension and vascular disease studies 50659 2
...t. 31 United,Therapeutics Corporation (Nasdaq: U...., announced today that they will release the resu... inhaled formulation of treprostinil,in pulmonary ...Thursday,November 1, 2007. United Therapeutics wi... on November 1, 2007, to a full hour to accommodat...
...stal Research,Associates, LLC announced today that...(R) (EIO(R)) on CEL-SCI Corporation (Amex: CVM )....ww.crystalra.com . CEL-SCI Corporation develops i...s. Its primary product candidate is Multikine(R), ...t targets treatment-naive,newly diagnosed head and...
Other Medicine Technology:Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation 3
Access Vitamin B12
Quantaphase II B12/RIA
Autoimmunity Screening Panel 1
...ies that have decided to change to the ELISA metho...A ANAs correlation with IFA and many user friendly...n. While no ELISA ANA currently on the market is c...A screen has been shown to be quite effective at d...
Medicine Products: